...
首页> 外文期刊>Expert opinion on drug delivery >Overcoming multiple drug resistance in cancer using polymeric micelles
【24h】

Overcoming multiple drug resistance in cancer using polymeric micelles

机译:使用聚合物胶束克服癌症中的多种耐药性

获取原文
获取原文并翻译 | 示例

摘要

ABSTRACT, Introduction: A major concern that limits the success of cancer chemotherapy is multidrug resistance (MDR). The drug resistance mechanisms are either host related or tumor related. The host tumor interacting factors also contribute to MDR. Multifunctional polymeric micelles offer several advantages in circumventing MDR due to their design, selectivity, and stability in cancer microenvironment. Areas covered: The review is broadly divided into two parts: the first part covers MDR and its mechanisms; the second part covers multifunctional polymeric micelles in combating MDR through its state-of-the-art design. This part covers various strategies like use of P-gp transporter inhibitors, TPGS, pH & thermo-sensitive, and siRNA for selectivity of PMs against multidrug-resistant tumors. Expert opinion: Numerous approaches have been tested using polymeric micelles to overcome MDR tumors. However, these are either limited to only in-vitro investigations and/or preliminary preclinical models and do not investigate the underlying biological mechanism. Hence, there exists an unmet need to perform fundamental research that focuses on studying the underlying mechanism and preclinical/clinical testing of the micellar formulations.
机译:摘要,介绍:限制癌症化疗成功的主要关切是多药抗性(MDR)。耐药机制是宿主相关或肿瘤相关的。宿主肿瘤相互作用因子也有助于MDR。多官能聚合物胶束由于其设计,选择性和癌细胞上的设计,选择性和稳定性而在绕过MDR来提供多种优点。所涵盖的区域:审查大致分为两部分:第一部分涵盖了MDR及其机制;第二部分通过其最先进的设计覆盖在调用MDR中的多官能聚合物胶束。该部分涵盖了P-GP转运蛋白抑制剂,TPGS,pH和热敏和siRNA的各种策略,用于针对多药抗性肿瘤的PMS选择性。专家意见:使用聚合物胶束测试了许多方法以克服MDR肿瘤。然而,这些可以仅限于体外研究和/或初步临床前模型,并且不研究潜在的生物机制。因此,存在未满足的需要进行基础研究,专注于研究胶束制剂的潜在机制和临床前/临床测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号